Intravenous IV Therapy and Vein Access Market to grow by USD 6.78 billion from 2022 to 2027 | Technological advancement in IV solutions is a major trend - Technavio

2023-08-22
NEW YORK, Aug. 22, 2023 /PRNewswire/ -- The
intravenous IV therapy and vein access market size is estimated to grow by
USD 6,789.1 million at a
CAGR of 5.01% between 2022 and 2027, according to Technavio –
Download a Sample Report
Intravenous IV Therapy and Vein Access Market Insights -
Continue Reading
Intravenous IV Therapy and Vein Access Market to grow by USD 6.78 billion from 2022 to 2027 | Technological advancement in IV solutions is a major trend - Technavio
Preview
来源: PRNewswire
Technavio has announced its latest market research report titled Global Intravenous IV Therapy and Vein Access Market 2023-2027
Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and company landscape; company product insights and recent developments; key companies; and market positioning of companies
Segments: end-user (hospitals, clinics, and ambulatory surgical centers), application (medication administration, blood-based products, nutrition, buffer solution, and volume expander), and geography (North America, Europe, Asia, and Rest of the World (ROW))
To understand more about the intravenous IV therapy and vein access market, request a sample report
Intravenous IV Therapy and Vein Access Market - Company Insights
The growing competition in the market is compelling companies to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market companies, including - AngioDynamics Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic Plc, Poly Medicure Ltd., Smith and Nephew plc, Tekni Plex Inc., Teleflex Inc., Terumo Corp., and Vygon SAS.
Intravenous IV Therapy and Vein Access Market –
Market Dynamics
Key driver
The increasing prevalence of chronic diseases is a key factor driving market growth.
Major Trends
Technological advancements in IV solutions is a major trend in the market.
The high cost of IV solutions is a significant challenge restricting market growth. The increase in costs is due to various factors, including expensive raw materials, manufacturing processes, and transportation. This increase results in a decrease in the need for IV therapy and vein access. Healthcare providers and patients find these options unaffordable. As a result, manufacturers and distributors of these systems are experiencing reduced profits due to high costs. Furthermore, Healthcare providers are choosing more economical options like oral or subcutaneous injections to keep costs down. Hence, the high cost of IV solutions is expected to restrict market growth during the forecast period.
Drivers, Trends & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report!
The intravenous IV therapy and vein access market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as prospects.
Why Buy?
Add credibility to the strategy
Analyzes competitor's offerings
Get a holistic view of the market
Grow your profit margin with Technavio
- Buy the Report
What are the key data covered in this Intravenous IV Therapy and Vein Access Market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the intravenous IV therapy and vein access market between 2023 and 2027
Precise estimation of the size of the intravenous IV therapy and vein access market and its contribution to the market with a focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the intravenous IV therapy and vein access market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market's competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of intravenous IV therapy and vein access market companies.
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports
The
laparoscopic devices market is estimated to grow by USD 4,396.16 million at a CAGR of 8.11% between 2022 and 2027. This laparoscopic devices market report extensively covers market segmentation by product (instrument, accessories, and laparoscopes), end-user (hospitals, clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Growing demand for laparoscopic bariatric surgeries is an emerging trend shaping the market.
The
cranial orthoses market is estimated to grow by USD 136.94 million at a CAGR of 9.22% between 2022 and 2027. These cranial orthoses market report extensively covers market segmentation by application (plagiocephaly, scaphocephaly, and brachycephaly), type (active helmets and passive helmets), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). New FDA-approved devices are expected to drive market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Historic Market Size
Five Forces Analysis
Market Segmentation by End-user
Market Segmentation by Application
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。